No difference in virulence was observed between mice receiving tetracycline and control animals. In conjunction, these data suggest that TbrPPX1 may not be an essential gene in bloodstream form T. brucei, neither

in cell culture nor during an in vivo infection. Figure 5 RNAi against TbrPPX1 does not affect proliferation of bloodstream forms in culture. Panel A: Northern blot of two independent bloodstream form clones at 48 h after induction of RNAi. Panel B: determination of generation times in the presence and absence of tetracycline. wt: NYSM parental strain, A3, A5: two independent clones expressing RNAi against TbrPPX1. The figure represents one of two independent experiments. Characterization of recombinant TbrPPX1 TbrPPX1 Selleck RXDX-101 was expressed in E. coli BL21(DE3) cells as a fusion

protein with either an N-terminal GST tag or an N-terminal MBP tag, using the pGST- or pMBP parallel3 vectors [19]. Induction of protein expression with 0.4 mM IPTG overnight at 15°C resulted in mostly soluble fusion protein. The recombinant proteins were isolated by passage over glutathione- or amylose-resin. Both recombinant proteins migrated with the expected molecular masses (TbrPPX1: 42.8 kDa; GST: 26.2 kDa; MBP: 41.2 kDa). Initial activity measurement using pentaAZD5363 sodium triphosphate as AZD6244 cell line a substrate demonstrated that the GST-fusion protein was active, while the MBP fusion construct was completely inactive. In contrast to what was observed with LmjPPX1 [14], recombinant TbrPPX1 was stable after purification, and could be frozen and thawed repeatedly without loss

of activity when kept in elution buffer containing 10% glycerol and 0.5 mM MgCl2. As expected from its sequence, TbrPPX1 proved to be an exopolyphosphatase. Its Km for pentasodium triphosphate as a substrate is 27.2 ± 4.2 μM (n = 3), and its kcat is 8.1 ± 1.5 s-1 (n = 3). Sodium pyrophosphate (Figure 6B) and polyphosphate (average length ~ 17) are neither substrates nor inhibitors. The activity of TbrPPX1 is entirely dependent on divalent cations, and it is not affected by cAMP, deoxynucleoside triphosphates, ATP, sodium pyrophosphate, by basic amino acids that Sirolimus in vivo are enriched in the acidocalcisomes such as arginine, or by long polyanions such as heparin or RNA (Figure 6C). Also, TbrPPX1 is not inhibited by a series of cyclic nucleotide phosphodiesterase inhibitors such as Ro-20-1724, sildenafil, zaprinast, papaverine or etazolate, or the sodium salts of vanadate, fluoride or sulfate. Zn2+ is a strong inhibitor with an IC50 value of 21.3 ± 18.2 μM (n = 3) when the reaction is run in the presence of 1 mM MgCl2 (Figure 6D). Figure 6 Characterization of recombinant TbrPPX1. Panel A: Michaelis-Menten kinetics with pentasodium triphosphate as substrate. Each assay point was done in triplicate (standard deviations are too small to be visible in the graph). A representative graph of three independent experiments is shown. Panel B: Sodium pyrophosphate is neither a substrate for, nor an inhibitor of TbrPPX1.